15 ML natalizumab 20 MG/ML Injection

RxCUI: 477484
RxNorm name: 15 ML natalizumab 20 MG/ML Injection
Display name: 15 ML natalizumab 20 MG/ML Injection
Full name: 15 ML natalizumab 20 MG/ML Injection
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:20

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
125104	Tysabri	natalizumab	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
TYSABRI	NATALIZUMAB	Biogen Inc.	c5fdde91-1989-4dd2-9129-4f3323ea2962	2025-03-21	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 477484

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
c5fdde91-1989-4dd2-9129-4f3323ea2962	15 ML natalizumab 20 MG/ML Injection	SCD	47	These highlights do not include all the information needed to use TYSABRI safely and effectively. See full prescribing information for TYSABRI. TYSABRI (natalizumab) injection, for intravenous use Initial U.S. Approval: 2004	20250321
c5fdde91-1989-4dd2-9129-4f3323ea2962	natalizumab 300 MG in 15 ML Injection	PSN	47	These highlights do not include all the information needed to use TYSABRI safely and effectively. See full prescribing information for TYSABRI. TYSABRI (natalizumab) injection, for intravenous use Initial U.S. Approval: 2004	20250321
c5fdde91-1989-4dd2-9129-4f3323ea2962	natalizumab 300 MG per 15 ML Injection	SY	47	These highlights do not include all the information needed to use TYSABRI safely and effectively. See full prescribing information for TYSABRI. TYSABRI (natalizumab) injection, for intravenous use Initial U.S. Approval: 2004	20250321